SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-060862
Filing Date
2017-11-15
Accepted
2017-11-15 16:09:36
Documents
2
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8501
2 POA DOCUMENT poa.txt EX-24.4_752212 4547
  Complete submission text file 0001209191-17-060862.txt   14476
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Issuer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 500 LEXINGTON MA 02421
Business Address
Stuart Nancy (Reporting) CIK: 0001594774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36310 | Film No.: 171205322